Efficacy and safety of decitabine combined with arsenic trioxide in elderly high-risk myelodysplastic neoplasm patients: a retrospective study

This study underscores the clinical relevance of this regimen, warranting further investigation in prospective trials.

Authors

Institutions

Publication Details

Journal
Hematology
Published
2025-04-01
DOI
https://doi.org/10.1080/16078454.2025.2485493
Citations
1
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
1.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of decitabine combined with arsenic trioxide in elderly high-risk myelodysplastic neoplasm patients: a retrospective study

Jianzhong Yang
1 citations
Hematology
Acute Myeloid Leukemia Research
1.77
article

Efficacy and safety of decitabine combined with arsenic trioxide in elderly high-risk myelodysplastic neoplasm patients: a retrospective study

Jianzhong Yang
article en
1 citations

Abstract

This study underscores the clinical relevance of this regimen, warranting further investigation in prospective trials.

HematologyVol. 30(1)
Fujian Medical University (CN)
Good health and well-being
Openalex Percentile: Top 18%
Acute Myeloid Leukemia Research
1.77
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of decitabine combined with arsenic trioxide in elderly high-risk myelodysplastic neoplasm patients: a retrospective study — Jianzhong Yang · Hematology (2025) | TGRS Research Map | TGRS